Extremely High Cost Drugs

July 29th, 2017
bio, ideas
Let's say a company discovers a new drug that's far more effective than the current standard of care. [1] They get it through clinical trials, it still looks amazing, then they start selling it. But they set the price incredibly high.

My understanding is that insurance companies in the US are not allowed to refuse to cover a drug on the basis of cost, and they're not allowed to have limits on what they'll pay for someone's care. So what happens? Why aren't new drugs much much more expensive than they currently are?

Update 2017-08-01: From the comments it sounds like it's coinsurance (percentage co-pays) on high cost drugs that keeps this in check.


[1] If it's only a little bit better the insurance company could argue "sure it looks good in your N=500 tests, but we don't think this effect will hold up" or something. But if it's plainly much better then they wouldn't be successful with this I think?

Comment via: google plus, facebook

Recent posts on blogs I like:

Development RCTs Are Good Actually

In defense of trying things out

via Thing of Things March 25, 2024

Clarendon Postmortem

I posted a postmortem of a community I worked to help build, Clarendon, in Cambridge MA, over at Supernuclear.

via Home March 19, 2024

How web bloat impacts users with slow devices

In 2017, we looked at how web bloat affects users with slow connections. Even in the U.S., many users didn't have broadband speeds, making much of the web difficult to use. It's still the case that many users don't have broadband speeds, both …

via Posts on March 16, 2024

more     (via openring)